Navigation Links
Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units
Date:11/10/2008

ing expenses and excluding any future proceeds from the exercise of the warrants issued in the financing.

About Cardium

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sale of innovative therapeutic products and devices for cardiovascular, ischemic and related indications.

Cardium's InnerCool Therapies subsidiary is a San Diego-based medical technology company in the emerging field of temperature modulation therapy to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events such as cardiac arrest or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about Cardium's InnerCool subsidiary and patient temperature modulation, including InnerCool's new RapidBlue(TM) System, which just received FDA clearance, and its CoolBlue(TM) System, please visit http://www.innercool.com.

Cardium also has two biologic candidates in clinical development. Cardium's Tissue Repair Company subsidiary (TRC) is focused on the development of growth factor therapeutics for the treatment of severe chronic diabetic wounds. TRC's lead product candidate, Excellarate(TM), is a DNA-activated collagen gel for topical treatment formulated with an adenovector delivery carrier encoding human platelet-derived growth factor-BB (PDGF-BB). Excellarate(TM) is initially being developed to be administered once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) (GAM) technology include therapeutic angiogenesis (cardiovascular ischemia, peripheral arterial disease) and orthopedic products, including hard tissue (bone) and soft tissue (ligament, tendon, cartilage) repair. For mor
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
2. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
3. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
4. Cardium Announces Follow-On Direct Investment by Institutional Investor
5. Cardium Selected for Inclusion in Russell Microcap Index
6. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
7. Cardium Launches New AWARE Clinical Study Website
8. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
9. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
10. Cardium Reports on First Quarter 2008 Highlights and Financial Results
11. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...a., Nov. 9 /PRNewswire-Asia-FirstCall/ -- BMP Suns...or the "Company"), today announced,financial resul... , , Third Quarter 2009 Financial Highlights I...from $30.5 million in the prior year, period...arly in, licensed products;, -- Gross mar...
(Date:11/9/2009)...Newswire-Asia-FirstCall/ -- Yongye International, ...a leading manufacturer, developer,and distributor ...ducts in the,People,s Republic of China (PRC), tod...l at 10:00 a.m. Eastern Time (11:00 p.m. Beijing T...ts for the quarter ended September 30, 2009. ,,...
(Date:11/9/2009)...RNewswire-Asia/ -- The pharma and biotech sectors ...mpanies are facing significant,pressure to change ...s, calls for,lower prices and a greater regulatory...ial crisis have made the work of creating new drug...re being forced to globalize their R&D,operati...
(Date:11/9/2009)...r of the top 10 pharmaceutical giants use Datafarm...th Canada. Datafarm’s announcement comes on ...nual Meeting where Health Canada stated that, effe...brid eCTD regulatory submissions for New Drug Subm... request. , Marlborough, ...
Breaking Biology Technology:BMP Sunstone Reports Third Quarter 2009 Financial Results 2BMP Sunstone Reports Third Quarter 2009 Financial Results 3BMP Sunstone Reports Third Quarter 2009 Financial Results 4BMP Sunstone Reports Third Quarter 2009 Financial Results 5BMP Sunstone Reports Third Quarter 2009 Financial Results 6BMP Sunstone Reports Third Quarter 2009 Financial Results 7BMP Sunstone Reports Third Quarter 2009 Financial Results 8BMP Sunstone Reports Third Quarter 2009 Financial Results 9BMP Sunstone Reports Third Quarter 2009 Financial Results 10BMP Sunstone Reports Third Quarter 2009 Financial Results 11BMP Sunstone Reports Third Quarter 2009 Financial Results 12Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3Pharma and Biotech Leaders to Converge in Shanghai 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2
...developments in technology have provided people wi...ayers, and cell phones with digital audio capabili... that may have been considered fantasy 10 years ag...s environment, companies must consider and underst...usiness arrangements with other parties, especiall...
...r,s note: Grady Frenchick co-authored this comment...ectual property associate with Whyte Hirschboeck D...spute over three important University of Wisconsi...lar disputes - shows a strong likelihood that the ... all of its patent rights, even if some of its cla...
... note: Matt Storms is writing a series of articles...nt focuses on the term sheet. , , Most of the ti... are summarized in what is referred to as a term ...s typical for the company to produce the initial t...s will want to negotiate the initial term sheet, e...
Other Biology Technology:Making deals with evolving technologies in mind 2Making deals with evolving technologies in mind 3Making deals with evolving technologies in mind 4Making deals with evolving technologies in mind 5WARF is likely to hold on to stem cell patent rights 2WARF is likely to hold on to stem cell patent rights 3WARF is likely to hold on to stem cell patent rights 4WARF is likely to hold on to stem cell patent rights 5WARF is likely to hold on to stem cell patent rights 6WARF is likely to hold on to stem cell patent rights 7WARF is likely to hold on to stem cell patent rights 8Capital-raising term sheets for angels and venture capitalists 2Capital-raising term sheets for angels and venture capitalists 3Capital-raising term sheets for angels and venture capitalists 4Capital-raising term sheets for angels and venture capitalists 5
(Date:11/6/2009)..., DETROIT, Nov. 6 Auburn Hill...LC (LEID) will be installing its locker system and...) (BACS) at the U.S. Department of Health and Huma...sed in Bethesda, MD. The locker system will suppo...le for protecting our nation,s medical research ag...
(Date:11/4/2009)..., PHILADELPHIA Although scientists are reluctant...ntion method, evidence continues to grow about its...udy published in Cancer Prevention Research , a j...arch, which suggests some reduction in oral cancer...or of medicine in the Department of Thoracic/Head ...
(Date:11/4/2009)..., The Singapore laboratory that deciphered the DN...ish) and elephant shark, has joined The Genome 10K...luable repository of DNA sequences on 10,000 speci...n a scale that currently can not be achieved. , ... in a paper published in the Nov. 5, 2009 issue of...
Breaking Biology News(10 mins):Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Singapore scientists join international study of 10,000 vertebrates' genomes 2National Foundation for Infectious Diseases honors VCU physician with Maxwell Finland Award for 2010 53744 1National Foundation for Infectious Diseases honors VCU physician with Maxwell Finland Award for 2010 53744 2National Foundation for Infectious Diseases honors VCU physician with Maxwell Finland Award for 2010 53744 3Smart Choices Program helps shoppers identify food and beverage choices 53741 1Smart Choices Program helps shoppers identify food and beverage choices 53741 2Beautiful plumage 3A Feather color and sex start the species revolution 9485 1
... Parasitic flies introduced to control red importe... central and southeast Texas since the flies, intr... Texas at Austin have discovered using new flytrap...ge Field Laboratory (BFL) have released multiple s...zil and Argentina, to control invasive fire ants w...
... Thanks to the many blood-safety interventions int...sfusion-transmitted infections has become exceedin... England Journal of Medicine, Dr. Morris Blajchman...d medical director, Canadian Blood Services (Hamil...as of Ottawa, puts into perspective the continuing...
... Researchers at Oregon Health & Science Univer...occurring brain substance, can relieve the doldrum...ective disorder, or SAD. The study is publishing o... Academy of Science. , The study was led by Alfred...pioneer in the study of circadian (24-hour) rhythm...
Other Biology News:Fire ant-attacking fly spreading rapidly in Texas 2Fire ant-attacking fly spreading rapidly in Texas 3Blood transfusion-transmitted infections: A global perspective 2Melatonin improves mood in winter depression 2
...tems adds two new Stem Cell Antibody Panels to its...mbryonic Stem Cell Marker Antibody Panel (Catalog ... phosphatase, Nanog, Oct-3/4, SSEA-1 and SSEA-4. T... Plus (Catalog # SC009) contains antibodies agains...
DONKEY SERUM (WITH 0.09% AZIDE) from AbD Serotec
...s Contact Printing Kit contains choice of Printing... Angsroms of Gold over Ti adhesion layer, 1 silico... adhesion layer, or 3 plain glass slides), PDMS St...100 / 200 micron squares or 100 um x 10 mm or 200 ...
Rabbit Anti-Human Melanoma antigen, family C, 1 (MAGEC1) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Biology Products: